Simple and effective embedding model for single-cell biology built from ChatGPT Nature.com
See more here:
Simple and effective embedding model for single-cell biology built from ChatGPT - Nature.com
Institute of Molecular and Cell Biology (IMCB) Agency for Science, Technology and Research (A*STAR)
Go here to see the original:
Institute of Molecular and Cell Biology (IMCB) - Agency for Science, Technology and Research (A*STAR)
Joseph Gall, father of modern cell biology, dead at 96 Carnegie Institution for Science
See the original post:
Joseph Gall, father of modern cell biology, dead at 96 - Carnegie Institution for Science
Shan, S. O. & Walter, P. Co-translational protein targeting by the signal recognition particle. FEBS Lett. 579, 921926 (2005).
Article CAS PubMed Google Scholar
Voorhees, R. M. & Hegde, R. S. Toward a structural understanding of co-translational protein translocation. Curr. Opin. Cell Biol. 41, 9199 (2016).
Article CAS PubMed Google Scholar
Rapoport, T. A., Li, L. & Park, E. Structural and mechanistic insights into protein translocation. Annu. Rev. Cell Dev. Biol. 33, 369390 (2017).
Article CAS PubMed Google Scholar
Zanetti, G., Pahuja, K. B., Studer, S., Shim, S. & Schekman, R. COPII and the regulation of protein sorting in mammals. Nat. Cell Biol. 14, 2028 (2011).
Article PubMed Google Scholar
Pantazopoulou, A. & Glick, B. S. A kinetic view of membrane traffic pathways can transcend the classical view of Golgi compartments. Front. Cell Dev. Biol. 7, 153 (2019).
Article PubMed PubMed Central Google Scholar
Nickel, W. & Rabouille, C. Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10, 148155 (2009).
Article CAS PubMed Google Scholar
Rabouille, C., Malhotra, V. & Nickel, W. Diversity in unconventional protein secretion. J. Cell Sci. 125, 52515255 (2012).
Article CAS PubMed Google Scholar
Malhotra, V. Unconventional protein secretion: an evolving mechanism. EMBO J. 32, 16601664 (2013).
Article CAS PubMed PubMed Central Google Scholar
Zhang, M. & Schekman, R. Cell biology. Unconventional secretion, unconventional solutions. Science 340, 559561 (2013).
Article CAS PubMed Google Scholar
Rabouille, C. Pathways of unconventional protein secretion. Trends Cell Biol. 27, 230240 (2017).
Article CAS PubMed Google Scholar
Dimou, E. & Nickel, W. Unconventional mechanisms of eukaryotic protein secretion. Curr. Biol. 28, R406R410 (2018).
Article CAS PubMed Google Scholar
Steringer, J. P. & Nickel, W. A direct gateway into the extracellular space: unconventional secretion of FGF2 through self-sustained plasma membrane pores. Semin. Cell Dev. Biol. 83, 37 (2018).
Article CAS PubMed Google Scholar
Schafer, T. et al. Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J. Biol. Chem. 279, 62446251 (2004).
Article PubMed Google Scholar
Duran, J. M., Anjard, C., Stefan, C., Loomis, W. F. & Malhotra, V. Unconventional secretion of Acb1 is mediated by autophagosomes. J. Cell Biol. 188, 527536 (2010).
Article CAS PubMed PubMed Central Google Scholar
Cruz-Garcia, D., Brouwers, N., Malhotra, V. & Curwin, A. J. Reactive oxygen species triggers unconventional secretion of antioxidants and Acb1. J. Cell Biol. 219, e201905028 (2020).
Article CAS PubMed PubMed Central Google Scholar
Lock, R., Kenific, C. M., Leidal, A. M., Salas, E. & Debnath, J. Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov. 4, 466479 (2014).
Article CAS PubMed PubMed Central Google Scholar
Villeneuve, J. et al. Unconventional secretion of FABP4 by endosomes and secretory lysosomes. J. Cell Biol. 217, 649665 (2018).
Article CAS PubMed PubMed Central Google Scholar
Ejlerskov, P. et al. Tubulin polymerization-promoting protein (TPPP/p25) promotes unconventional secretion of -synuclein through exophagy by impairing autophagosome-lysosome fusion. J. Biol. Chem. 288, 1731317335 (2013).
Article CAS PubMed PubMed Central Google Scholar
Claude-Taupin, A., Jia, J., Mudd, M. & Deretic, V. Autophagys secret life: secretion instead of degradation. Essays Biochem. 61, 637647 (2017).
Article PubMed Google Scholar
Zhang, M. et al. A translocation pathway for vesicle-mediated unconventional protein secretion. Cell 181, 637652 (2020).
Article CAS PubMed Google Scholar
Zhang, M., Kenny, S. J., Ge, L., Xu, K. & Schekman, R. Translocation of interleukin-1 into a vesicle intermediate in autophagy-mediated secretion. eLife 4, e11205 (2015).
Article PubMed PubMed Central Google Scholar
Dupont, N. et al. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1. EMBO J. 30, 47014711 (2011).
Article CAS PubMed PubMed Central Google Scholar
Rubartelli, A., Cozzolino, F., Talio, M. & Sitia, R. A novel secretory pathway for interleukin-1-, a protein lacking a signal sequence. EMBO J. 9, 15031510 (1990).
Article CAS PubMed PubMed Central Google Scholar
Rubartelli, A., Bajetto, A., Allavena, G., Cozzolino, F. & Sitia, R. Posttranslational regulation of interleukin-1- secretion. Cytokine 5, 117124 (1993).
Article CAS PubMed Google Scholar
Dirac-Svejstrup, A. B., Sumizawa, T. & Pfeffer, S. R. Identification of a GDI displacement factor that releases endosomal Rab GTPases from Rab-GDI. EMBO J. 16, 465472 (1997).
Article CAS PubMed PubMed Central Google Scholar
Goody, R. S., Mller, M. P. & Wu, Y. W. Mechanisms of action of Rab proteins, key regulators of intracellular vesicular transport. Biol. Chem. 398, 565575 (2017).
Article CAS PubMed Google Scholar
Pfeffer, S. R. Rab GTPases: master regulators that establish the secretory and endocytic pathways. Molec. Biol. Cell 28, 712715 (2017).
Article CAS PubMed PubMed Central Google Scholar
Wang, X. H. et al. SMGL-1/NBAS acts as a RAB-8 GEF to regulate unconventional protein secretion. J. Cell Biol. 221, e202111125 (2022).
Article CAS PubMed PubMed Central Google Scholar
Li, X. X. et al. Coordination of RAB-8 and RAB-11 during unconventional protein secretion. J. Cell Biol. 223, e202306107 (2023).
Pfeffer, S. R. Rab GTPase regulation of membrane identity. Curr. Opin. Cell Biol. 25, 414419 (2013).
Article CAS PubMed PubMed Central Google Scholar
Stenmark, H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 10, 513525 (2009).
Article CAS PubMed Google Scholar
Monetta, P., Slavin, I., Romero, N. & Alvarez, C. Rab1b interacts with GBF1 and modulates both ARF1 dynamics and COPI association. Mol. Biol. Cell 18, 24002410 (2007).
Article CAS PubMed PubMed Central Google Scholar
Saraste, J. Spatial and functional aspects of ERGolgi Rabs and tethers. Front. Cell Dev. Biol. 4, 28 (2016).
Article PubMed PubMed Central Google Scholar
Tisdale, E. J. & Jackson, M. R. Rab2 protein enhances coatomer recruitment to pre-Golgi intermediates. J. Biol. Chem. 273, 1726917277 (1998).
Article CAS PubMed Google Scholar
Westrate, L. M., Hoyer, M. J., Nash, M. J. & Voeltz, G. K. Vesicular and uncoated Rab1-dependent cargo carriers facilitate ER to Golgi transport. J. Cell Sci. 133, jcs239814 (2020).
Article CAS PubMed PubMed Central Google Scholar
Plutner, H. et al. Rab1b regulates vesicular transport between the endoplasmic reticulum and successive Golgi compartments. J. Cell Biol. 115, 3143 (1991).
Article CAS PubMed Google Scholar
Tisdale, E. J., Bourne, J. R., Khosravifar, R., Der, C. J. & Balch, W. E. GTP-binding mutants of Rab1 and Rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex. J. Cell Biol. 119, 749761 (1992).
Article CAS PubMed Google Scholar
Haas, A. K. et al. Analysis of GTPase-activating proteins: Rab1 and Rab43 are key Rabs required to maintain a functional Golgi complex in human cells. J. Cell Sci. 120, 29973010 (2007).
Article CAS PubMed Google Scholar
Sklan, E. H. et al. TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication. J. Biol. Chem. 282, 3635436361 (2007).
Article CAS PubMed Google Scholar
Thomas, L. L., Joiner, A. M. N. & Fromme, J. C. The TRAPPIII complex activates the GTPase Ypt1 (Rab1) in the secretory pathway. J. Cell Biol. 217, 283298 (2018).
Article CAS PubMed PubMed Central Google Scholar
Yin, J. et al. GOP-1 promotes apoptotic cell degradation by activating the small GTPase Rab2 in C. elegans. J. Cell Biol. 216, 17751794 (2017).
Article CAS PubMed PubMed Central Google Scholar
Riedel, F., Galindo, A., Muschalik, N. & Munro, S. The two TRAPP complexes of metazoans have distinct roles and act on different Rab GTPases. J. Cell Biol. 217, 601617 (2018).
Article CAS PubMed PubMed Central Google Scholar
Borchers, A. C., Langemeyer, L. & Ungermann, C. Whos in control? Principles of Rab GTPase activation in endolysosomal membrane trafficking and beyond. J. Cell Biol. 220, e202105120 (2021).
Article CAS PubMed PubMed Central Google Scholar
Overmeyer, J. H., Wilson, A. L. & Maltese, W. A. Membrane targeting of a Rab GTPase that fails to associate with Rab escort protein (REP) or guanine nucleotide dissociation inhibitor (GDI). J. Biol. Chem. 276, 2037920386 (2001).
Article CAS PubMed Google Scholar
Wu, Y. W. et al. Membrane targeting mechanism of Rab GTPases elucidated by semisynthetic protein probes. Nat. Chem. Biol. 6, 534540 (2010).
Article CAS PubMed Google Scholar
Wandinger-Ness, A. & Zerial, M. Rab proteins and the compartmentalization of the endosomal system. Cold Spring Harb. Perspect. Biol. 6, a022616 (2014).
Article PubMed PubMed Central Google Scholar
Saraste, J. & Marie, M. Intermediate compartment (IC): from pre-Golgi vacuoles to a semi-autonomous membrane system. Histochem. Cell Biol. 150, 407430 (2018).
Article CAS PubMed PubMed Central Google Scholar
Appenzeller-Herzog, C. & Hauri, H. P. The ERGolgi intermediate compartment (ERGIC): in search of its identity and function. J. Cell Sci. 119, 21732183 (2006).
Article CAS PubMed Google Scholar
Strating, J. R. P. M. & Martens, G. J. M. The p24 family and selective transport processes at the ERGolgi interface. Biol. Cell 101, 495509 (2009).
Article CAS PubMed Google Scholar
Blum, R. et al. Intracellular localization and in vivo trafficking of p24A and p23. J. Cell Sci. 112, 537548 (1999).
Article CAS PubMed Google Scholar
Schleinitz, A. et al. Consecutive functions of small GTPases guide HOPS-mediated tethering of late endosomes and lysosomes. Cell Rep. 42, 111969 (2023).
Read more here:
A dual role of ERGIC-localized Rabs in TMED10-mediated unconventional protein secretion - Nature.com
STRASBOURG, France, June 26, 2024 /PRNewswire/ -- The International Human Frontier Science Program Organization (HFSPO) is pleased to announce that acclaimed Japanese cell biologist and international research leader Yoshihiro Yoneda will assume the role of President for the global life science organization.
"We are thrilled to welcome President Yoneda, a pioneer in cellular biology and a science leader, who has made such positive impacts on key research institutions," said Pavel Kabat, HFSPO Secretary General.
Yoneda will serve as the 7th President in HFSPO's 35-year history, successor to President Shigekazu Nagata, who served from 2018 to 2024.
"It is with deep gratitude that we thank President Nagata for his years of service and dedication to HFSPO at all levels," said Kabat. "His wisdom and insight have been invaluable."
Chartered by the G7 in 1987, HFSPO supports pioneering, interdisciplinary research in the life sciences through Research Grants and Fellowships. It is funded by 16 Member countries, plus the European Commission. HFSP research proposals are evaluated through peer review and only the most daring, ground-breaking research all involving international collaboration is supported. HFSP has issued over 4,500 awards involving over 8,500 international scientists. Since the beginning of the Program,29 HFSP awardees have gone on to win the Nobel Prize.
Yoneda was nominated by the Government of Japan; the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); and the Ministry of Economy, Trade and Industry (METI); and unanimously confirmed during the June meeting of the HFSPO Board of Trustees, held this year in Washington, D.C.
He is Professor Emeritus at Osaka University and President of The Research Foundation for Microbial Diseases of Osaka University (BIKEN Foundation). From 2015 to 2022, he led the National Institutes of Biomedical Innovation, Health and Nutrition. He also served as Director of the World Health Organization Collaborating Centre for Nutrition and Physical Activity.
Yoneda has a longstanding connection to HFSPO. He was awarded two HFSP Research Grants in 1998 and 2001 that led to important discoveries in molecular mechanisms of nucleocytoplasmic transport.
"I am honored to be entrusted with this important role for such an impactful, global organization," said Yoneda. "HFSPO is one of the few organizations in the world focused on creating quantum leaps in scientific knowledge. Through such research we have a chance to do great things for humanity."
For more information or to schedule interviews, contact Rachael Bishop, Science Writer and Editor: phone: +33 (0)7 81 87 62 21 or email: [emailprotected]
The International Human Frontier Science Program Organization is headquartered at 12 Quai Saint-Jean, 67000, Strasbourg, France. http://www.hfsp.org | Office phone: +33-(0)3 88 21 51 23 | @HFSP Twitter | Facebook page
Photo - https://mma.prnewswire.com/media/2447736/HFSPO_President.jpg Logo -https://mma.prnewswire.com/media/2447737/Human_Frontier_Science_Program_35_Years_Logo.jpg
Continued here:
Yoshihiro Yoneda Appointed President of the International Human Frontier Science Program Organization - PR Newswire
image:
Visualization of a protein aggregation clock
Credit: ill./: Nike Heinss / JGU
--JOINT PRESS RELEASE OF THE INSTITUTE OF MOLECULAR BIOLOGY (IMB) AND JOHANNES GUTENBERG UNIVERSITY MAINZ --
Could measuring protein clumps in our cells be a new way to find out our risk of getting age-related diseases? Professor Dorothee Dormann and Professor Edward Lemke of Johannes Gutenberg University Mainz (JGU), who are also adjunct directors at the Institute of Molecular Biology (IMB) in Mainz, propose the concept of a "protein aggregation clock" to measure ageing and health in a new perspective article published inNature Cell Biology.
As we age, the DNA and proteins that make up our bodies gradually undergo changes that cause our bodies to no longer work as well as before. This in turn makes us more prone to getting age-related diseases, such as cardiovascular disease, cancer, and Alzheimer's disease. One important change is that the proteins in our cells can sometimes become misfolded and clump together to form aggregates, so-called amyloids. Misfolding and aggregation can happen to any protein, but a specific group of proteins known as intrinsically disordered proteins (IDPs) are especially prone to forming amyloids. IDPs make up around 30 percent of the proteins in our cells and they are characterized by having no fixed structure. Instead, they are flexible and dynamic, flopping around like strands of cooked spaghetti.
While the molecular mechanisms are widely debated and an important aspect of basic research, scientists know that aggregates formed from IDPs tend to accumulate in many long-lived cells such as neurons or muscle cells as we age. Moreover, they can cause many age-related diseases, particularly neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Thus, having many aggregates in a cell could be an indicator of how unhealthy the cell is or if a person is likely to develop an age-related disease soon. In their recently published article, Dormann and Lemke propose that IDP aggregation could be used as a biological "clock" to measure a person's health and age.
If developed further into a sensitive diagnostic test, a protein aggregation clock could be extremely useful. Firstly, doctors could use it to help diagnose age-related diseases at very early stages or identify people who are not yet sick but have a higher risk of developing disease as they age. This would allow them to be given preventative treatments before they develop severe disease. Secondly, scientists could use it to assess the effects of new experimental treatments to reduce protein aggregation in order to prevent or delay age-related diseases.
"In practice, we are still far away from a routine diagnostic test, and it is important that we improve our understanding of the fundamental mechanisms leading to IDP aggregation", said Dormann. "However, we want to stimulate thinking and research in the direction of studying protein aggregates to measure biological ageing processes," Lemke added. "We are optimistic that in the future we will be able to overcome the current challenges of reading a protein aggregation clock through more research on IDP dynamics and making further technological developments."
Although there are other "clocks" to measure ageing and health, most of them are based on nucleic acids like DNA. Dormann and Lemke think that a biological clock based on proteins would be a useful complement to these existing clocks, as proteins are among the most abundant molecules in cells and are crucial for all cellular functions. With the help of such a protein aggregation clock, they hope that scientists and doctors will be able to move one step closer towards helping people age healthily and preventing age-related diseases.
With their research, Dorothee Dormann and Edward Lemke contribute to the Center for Healthy Ageing (CHA), a virtual research center launched in 2021. The CHA brings together scientists in basic and clinical research from across Mainz who focus on ageing and age-related diseases. Their findings are to be used to promote healthy ageing and to find treatments that help prevent or cure age-related diseases.
Related links:
Contact: Professor Dr. Dorothee Dormann Molecular Cell Biology Institute of Molecular Physiology (IMP) Johannes Gutenberg University Mainz 55099 Mainz, GERMANY and Institute of Molecular Biology (IMB) 55128 Mainz, GERMANY phone: +49 6131 39-36206 e-mail: ddormann@uni-mainz.de https://www.blogs.uni-mainz.de/fb10-biologie-eng/about-the-faculty-of-biology/institutes/institute-of-molecular-physiology-imp/
Professor Dr. Edward Lemke Synthetic Biophysics Institute of Molecular Physiology (IMP) Johannes Gutenberg University Mainz 55099 Mainz, GERMANY and Institute of Molecular Biology (IMB) 55128 Mainz, GERMANY phone: +49 6131 39-36118 e-mail: edlemke@uni-mainz.de https://lemkelab.uni-mainz.de/
Read more:
Nature Cell Biology
Adding intrinsically disordered proteins to biological ageing clocks
23-May-2024
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
See the rest here:
A new way to measure ageing and disease risk with the protein aggregation clock - EurekAlert
In the mid-twentieth century, Louis Kamentsky, an engineer at Columbia University at the time, searched for a convenient approach for differentiating cancerous and normal cells. He modified a cell counting device that arranged samples into a single-file line by mounting an oscilloscope to measure their absorption and scattering of light as the cells passed through a flow tube.1-4
Around the same time, Mack Fulwyler, an engineer working at Los Alamos National Laboratory, needed to separate particles, so he drew on existing techniques to create droplets to separate cells from a flow stream based upon charge that correlated to their volume.5,6 These approaches laid the foundation for flow cytometry, which is now a staple in biological research.
All of the methodology that existed before flow cytometry suddenly could be applied to the single cell, said Thomas Jovin, a biophysicist at the Max Plank Institute who developed advancements to the instruments in the 1970s as flow cytometry emerged as a major player in the research space.
Flow cytometry entered biomedical research in immunology and cancer labs out of initial interests in separating and counting cells in a mixed population, but groups also developed instruments purely to characterize cells.7,8 The flow cytometer and the flow sorter are not separate instruments, explained Jovin. The flow sorter requires that it be a flow cytometer at the same time because you have to make the same measurement. Its just that youre using it to process the cell after it has gone through the detection system. Today, instruments that both analyze and sort cells are referred to as flow sorters and those that do not are called flow analyzers.
Initially, flow measurements were based on fluorescent light emitted from dyes that researchers used to identify genetic material, but soon after, scientist also determined the cells size based on its light-scatter patterns.9, 10 These first instruments used lamps as their light source, but this soon changed. The lasers came along very quickly, Jovin said. They were important because you could focus a laser down to microns, whereas you cant do that with a large optical source like a lamp.
You can measure essentially anything in, on, or produced by a cell at a high rate of speed in a heterogeneous solution at a rapid rate.
Jonni Moore, University of Pennsylvania
Soon, researchers added more lasers to their instruments to expand the colors they could detect and developed methods to analyze and sort cells labeled with two fluorescent molecules.11,12 With the help of dichroic mirrors and bandpass filters that reflect and isolate, respectively, specific wavelengths of light to dedicated detectors, scientists could funnel the signal from multiple parameters to specific detectors to study more features of their samples.13
As the parameters that flow systems used expanded, data poured out of labs globally. You have a lot of signals that have been processed in real time, and you have to make decisions, in the case of the sorter, in real time, because otherwise your cells wont be there anymore, Jovin said. The only way to do that was by computation. Jovin and his team developed a computer-controlled flow cytometry instrument that facilitated the data analysis process.14
With the ability to rapidly assay and separate cells of interest from a mixed population based on multiple parameters, flow cytometry rivaled its predecessor, microscopy, in the study of cells. Jonni Moore, an immunologist and the director of the shared resource laboratory at the University of Pennsylvania, recalled using a flow cytometer for the first time after only having used a fluorescent microscope during graduate school. I thought I had died and gone to heaven, she said. According to Moore, classifying T lymphocytes on the microscope took several hours longer than the seconds it took her to analyze thousands of cells by flow cytometry. It really allowed me to ask a lot more questions in my research, Moore said.
While some research focused on the ability to analyze cell properties with flow systems, many groups used flow cytometry for its sorting capacity.15 However, as scientists developed new dyes, they could use flow cytometry to analyze more cellular parameters, such as mitochondrial activity and the quantity of particular receptors on cells.16-18
Flow cytometry analysis expanded into the clinical setting by helping streamline the quantification of CD4+ T cells during the human immunodeficiency virus (HIV) epidemic. Compared to microscopy, flow cytometry analysis was faster and more reliable.19, 20 Over the next 30 plus years, analytical cytometry exploded as we realized that we could measure virtually anything in, on, or produced by a cell, in multiple populations at the same time, Moore said.
Today, researchers still use flow cytometry to analyze a population of cells based on the presence of surface markers tagged with a fluorescent antibody or other probe. However, these analyzers can also use dyes and other techniques to investigate cellular functions, such as metabolism and protein secretion.21, 22 Researchers can assess cell proliferation and death with flow cytometry by measuring the dilution of dye or uptake of it.23, 24 While various individual methods exist that can measure the amount of protein or other mediators produced by cells or their activity, they require researchers to do them separately. The technology of flow cytometry, as it exists today, allows you to do all of that together, Moore said.
However, despite measuring an entire population of cells, flow cytometry is a single-cell technique. Because youve dissociated tissues and youve put these objects into kind of single file, youve lost where theyre seated next to one another, explained Lisa Nichols, the director of the flow cytometry facility at Stanford University. That level of spatial information requires microscopy. Nonetheless, flow cytometry produces high dimensional information on individual cells, and in contrast to other single cell techniques, does so more quickly on larger populations. Flow cytometry can actually go through and get you the results from millions of cells in a matter of minutes, Nichols said.
A high-throughput, single-cell method enables researchers to assess several cell parameters simultaneously with the help of lasers.
Scientists prepare samples as single cell suspensions and labels components of interest with fluorescent antibodies or other probes. The cytometer uses pumps to draw the sample through tubing to analyze it.
Using hydrodynamic focusing the instrument injects the sample into a fast-moving stream of fluid that funnels the sample single file through a narrow channel.
The channel leads to a point where the individual cells intersect with one or more lasers. The measured sample is deposited into a waste receptable after it passes this point.
As a cell begins to cross the laser beam, it scatters light. Light that mostly crosses the cell is detected as forward scatter and measures the cells size. Light that encounters obstacles in the cell changes direction and is detected by a side scatter detector, indicating the granularity of the cell. If the lasers excite fluorescent molecules in the cell, the emitted light is channeled through dichroic mirrors and bandpass filters to isolate specific wavelengths that meet detectors specific for those wavelengths.
Ashleigh Campsall
Fluorescent probes have come a long way since the 1960s. Researchers have added lasers and probes that recognize the violet and infrared range, as well as expanded probes into quantum dots, or inorganic nanocrystals.25-27 These additions greatly expanded the available colors for researchers to use, but introduced new challenges, as more color parameters increased the likelihood of overlapping spectra from these probes. As those overlaps increase, your ability to resolve very dim signals is compromised, said Nichols.
In traditional cytometers, to minimize overlapping signals from multiple fluorescent probes, the instrument doesnt use all of the light energy that a molecule emits. We take that whole spectrum, and we take a slice of it. And we measure that slice, said Timothy Bushnell, the flow cytometry core director at the University of Rochester. Mirrors and bandpass filters only permit a certain range of wavelengths to reach their detectors, which usually correspond to the peak emission spectra of commonly used probes.
While this method simplifies the problem of overlapping spectra in multiparameter experiments, it eliminates potentially valuable information. This prompted the development of spectral analyzers, which capture a fluorescent molecules full emission spectrum.28, 29 We now get the whole picture of what that spectrum looks like, Bushnell said.
Using single-labeled and unlabeled controls, the instrument accesses the entire spectrum of these samples to calculate the distinct emission spectra of each color from the mixed readout. The introduction of spectral flow cytometry enabled researchers to conduct multidimensional analyses. It lets you have more flexibility in what fluorochromes you use because youre not confined to this one detector, one fluorochrome phenomenon, Bushnell said. These advancements come in tandem with improved detector technology, such as swapping out current photomultiplier tubes for silica-based models that pick up longer wavelengths better.30
While flow cytometry enables a high dimensional analysis of individual cells within a population, researchers cannot see where their target of interest is within or on the cell. Our resolution is basically a dot on a plot, Bushnell said. This type of resolution traditionally had to be done with microscopy, but at the expense of time and quantity of cells analyzed. The introduction of imaging cytometry is changing that.31
Image flow cytometers capture an image of a cell as it flows through transit. We could combine the power of knowing where something is, so seeing where it is in the cell, with the statistics that flow can give you, Bushnell said.
Anything you can actually make into a particulate solution and put a fluorescent tag on, you can now measure.
Lisa Nichols, Stanford University
You are limited by the fact that it is flow, so these things are moving, Nichols said. Youre never going to get the resolution youre going to get with a microscope where its sitting still. Although not in the resolution possible with microscopy, the photographs provide additional information about where signal originates from within and on a sample.
Additionally, having been available for flow cytometry analyzers for more than a decade, this imaging capacity is becoming available for flow cytometry sorters.32 One setback in this application is the ability to take an image rapidly and interpret that image to make a decision for a falling samples fate. Things are moving so fast, you need to do one of two things, Nichols said. You either have to have a whole bunch of predetermined features that youre looking for that can be matched to each individual cell, or you have to have AI and computing technologies.
Not only will the rapid computing power of machine learning be necessary for quick sorting decisions, but as flow cytometry becomes increasingly multiparametric, researchers forgo the traditional bivariate plots for computational analyses already used in single-cell sequencing analyses.33-35 When you look at dot plots, two by twos, you only ever see the elephant foot. You can never see the whole elephant by doing that, said Moore. This opens the opportunity to explore and interpret data in completely new ways, possibly by introducing previously overlooked findings in datasets.
Beyond crunching the numbers in individual experiments, machine learning may offer the ability to account for variations between experiments, or batch effects. Even more broadly, these intelligent tools may be imperative for comparing and combining analyses between different institutions, confidently enabling collaborations.36
Flow cytometry is not restricted to cells. Anything you can actually make into a particulate solution and put a fluorescent tag on, you can now measure, said Nichols. With the help of microfluidic technology, instruments analyze everything from metal nanoparticles and microplastics to exosomes.37-40 These droplets have also paved the way for studying materials typically released from cells, including antibodies and other proteins and may soon be compatible with existing flow systems.41-43 Meanwhile, specially developed cytometers with the ability to more accurately measure the small scale of microparticles advance the research potential of this field.44, 45 All of these developments aim to push flow cytometry to its next limit.
References
Read more from the original source:
How Flow Cytometry Spurred Cell Biology - The Scientist
designed by erin lemieux
In pursuit of a deeper understanding of cellular life, biologists use patterns in data as a springboard for probing specific elements in complex systems. Delete a gene here; express a protein there; and through these meticulous molecular manipulations, the components necessity and sufficiency emerges, bringing clues about the nuts and bolts of cellular functioning. In recent decades, scientists from fields outside of the life sciences have entered the biological arena, bringing with them a potpourri of alternative perspectives and approaches for studying complex systems.
Cees Dekker, a biophysicist at Delft University of Technology (TU Delft), is part of a growing community of synthetic biologists who are exploring the design principles of living systems by engineering cells from the bottom up.1 Just by engineering it, you are faced with certain problems that you didnt realize when you were studying the system top-down, said Dekker, echoing a sentiment put forth by the late physicist Richard Feynman, who once said, What I cannot create, I do not understand.
Just by engineering it, you are faced with certain problems that you didnt realize when you were studying the system top-down.
Cees Dekker, Delft University of Technology
In the future, synthetic cells may become factories that produce proteins and deliver drugs to treat human disease, but for now, they reside in the realm of curiosity-driven research with the goal of answering fundamental questions about biology. Dekkers dream is to create a synthetic cell from a minimal collection of functional components.2 However, en route to this goal, he needed to learn how to build biology, and how to become a biologist, from the bottom up.
What I appreciated about [Dekker] was that he was always going for the big aim, for the very juicy target, said Nicola De Franceschi, a molecular biologist at the International Institute of Molecular Mechanisms and Machines and former postdoctoral researcher in Dekkers team.
At the end of the 1990s, a 40-year-old Dekker reflected on what he wanted to do with the next 30 or so years of his career. Up until then, he researched solid-state physics and nanotechnology; he worked on superconductors, explored how electrons traverse carbon nanotubes, and developed the first carbon nanotube transistor.3 Although he found the work rewarding, his interests were changing along with the zeitgeist of the turn of the century. There was a mood that solid-state physics is 20th century, and in the 21st century, the big open questions are really in biology, said Dekker. Fascinated by the immense complexity of cellular life, he rerouted his research agenda.
Cees Dekker, a biophysicist at Delft University of Technology, started his career working on quantum effects in semiconductors. Now, he works to build fully autonomous synthetic cells from minimal components.
Wilmar Dik
A curiosity about molecular motorsproteins that gobble up energy molecules to fuel their transport throughout the celldrove him to attend an ATP synthase conference. He eagerly sat through every talk. I didnt know anything about it, but I was totally fascinated by it, said Dekker, who hit the ground running. He added, I even started studying first year cell biology books.
To support this transformation, his lab needed a makeover: ultra-high vacuum millikelvin scanning tunneling microscopes made way for polymerase chain reaction machines and protein purification reagents. However, Dekker didnt leave everything from his past behind; he leveraged his background in nanotechnology to ease his entry into the biological sphere. His team has since developed nanotechnology-based single-molecule techniques to sequence single proteins, tease apart DNA-protein interactions, and probe how bacteria organize and distribute their chromosomes during replication.4-6
In the last decade, Dekker expanded his research portfolio further into the synthetic world to get closer to understanding natures blueprint. Im intrigued to understand the spatial and temporal organization of molecules that together form a system that has the attributes of life. Single DNA molecules are not alive; single proteins are not alive; but the combination of these hundreds of components makes an object that can grow, divide, sustain itself, evolve over time, and all that. I find that intriguing, said Dekker.
In 2016, biotechnologist Craig Venter and his colleagues at the eponymous J. Craig Venter Institute stripped down the genome of Mycoplasma mycoides to the bare minimum 473 genes required to sustain a living bacterium.7,8 After chemically synthesizing the genome, they transplanted it into an empty host. And then there was life! These synthetic microbes exhibited behaviors of living bacteria, including colony formation and continuous self-replication.
This top-down approach of genetic plug and play to filter out nonessential genes gives scientists new insights into the basic biology of life and whole-genome design. However, complex systems are incompletely defined or understood, as evidenced by the 149 genes of unknown function in Venters minimal synthetic genome. Flipping the script, some scientists are building synthetic cells from the bottom-up to ask fundamental questions in biology. Dekkers current quest is to discover the minimal components a cell needs to divide, a fundamental feature of cell life.
I even started studying first year cell biology books.
Cees Dekker, Delft University of Technology
He was, from the beginning on, someone who looked at this problem really from an engineering perspective, said Oskar Staufer, a biophysicist at the Leibniz Institute for New Materials and a peer in the synthetic biology field. Staufer noted that Dekkers techniques for building synthetic cells influenced his own research.
The first step in building a synthetic cell was to create a chassis to contain the synthetic machinery.9 Liposomes fit the bill since they are versatile, efficient, and easy to assemble. To build liposomes in the lab at scale, Dekker harkened back to his physics days where he created new equipment to test hypotheses. He and his team engineered a microfluidic system to encase an aqueous solution in a lipid membrane.10 A previous study showed the potential of such an approach using the alcohol oleic acid to shuttle lipids along as they developed into an outer bilayer.11 However, oleic acid takes more than 15 hours to separate from the newly formed liposome, a timeframe that could render potential cargo useless due to molecular and enzymatic degradation.
With speed in mind, Dekker and his team explored alternative lipid-carrying solutions and landed on the alcohol 1-octanol. Like a miniaturized bubble blowing machine, a solution consisting of 1-octanol and dissolved lipids envelopes an aqueous phase, and as this passes through a second aqueous phase, a droplet gets pinched off and dumped into a sea of vesicles. Within minutes, the encasing solution begins to separate; the dissolved lipids assemble into an outer membrane and the 1-octanol pools to the side of the vesicle before separating completely from the nascent liposome. They called the method octanol-assisted liposome assembly.
[Dekker] sees molecules as machines that perform functions, and that is not the typical perspective a biologist would have, said Stauffer. Because he perceives them as a machine, he can also take a screwdriver and start to tweak them and modify them to do certain functions.
To generate synthetic cells at scale, Dekker and his team created a novel microfluidic device. The octanol-assisted liposome assembly system produces a versatile chassis for shuttling molecular machineries.
Siddharth Deshpande, Cees Dekker
Dekker has been focusing on incorporating synthetic modules for cell division into his liposomes, borrowing inspiration from living cells along the way. Dekker is not alone in his efforts; others have found that a cocktail of five proteins successfully assembled a ring-shaped structure that emerges in the build up to bacterial cell division; however, these cell mimics have not achieved autonomous cell division.12
In what Staufer said was a major breakthrough for synthetic biology, Dekker and his team recently published their findings on a simple, straightforward module capable of inducing the complete separation of synthetic daughter cells, making it the first synthetic system capable of autonomous cell division.13,14 To achieve this milestone, they incorporated external DNA nanoparticles to coerce the liposomes into the classic dumbbell formation that occurs during late-stage natural cell division.15Alongside these synthetic membrane shapers, Dekker and his team added the bacterial protein dynamin A, which accumulates at points of high curvaturesuch as the neck of the dumbbell liposomeand triggers full separation of the membrane.
He was able to focus and also helped me to focus on the real objective, and that was very inspiring, said De Franceschi, who helped build these synthetic systems for cell division.
Researchers interest in building biological complexity from the ground up has burgeoned over the last two decades. This synthetic cell effort is something that no single group can do. Its really a joint effort. Its super multidisciplinary, said Dekker, who is a member of the European Synthetic Cell Initiative, which is coordinated by TU Delft.
Molecular puppeteers are developing minimal synthetic modules to mimic other important cell functions, including chromosomal configuration, transcription and translation, and DNA replication and segregation. The next phase is going to be the most challenging one, said Dekker. On their own, each system presents a unique set of considerations and challenges. However, scientists must also find a way to integrate the different modules to maintain the spatial and temporal fidelity that is required to build a prototype synthetic cell.13 Thats our dream, said Dekker, who hopes to adopt emerging artificial intelligence and directed evolution techniques to tackle these challenges.
Given Dekkers experience with the protein mechanics of cell division and the organization of DNA, Staufer noted, That will be very important when one aims to achieve synthetic cell division, and the division of any kind of a genetic polymermost likely DNAinto daughter cells. That combination of expertise is very rare in the field.
References
The rest is here:
Building Cells from the Bottom Up - The Scientist
It began with little pieces of embryos scooting around in a dish. In 1998, these unassuming cells caught the attention of Michael Levin, then a postdoctoral researcher studying cell biology at Harvard University. He recalled simply recording a video before tucking the memory away. Nearly two decades later, Levin, now a developmental and synthetic biologist at Tufts University, experienced a sense of dj vu. He observed that as a student transplanted tissues from one embryo to another, some loose cells swam free in the dish.
Levin had a keen interest in the collective intelligence of cells, tissues, organs, and artificial constructs within regenerative medicine, and he wondered if he could explore the plasticity and harness the untapped capabilities of these swirling embryonic stem cells. At that point, I started thinking that this is probably an amazing biorobotics platform, recalled Levin. He rushed to describe this idea to Douglas Blackiston, a developmental and synthetic biologist at Tufts University who worked alongside Levin.
At the time, Blackiston was conducting plasticity research to restore vision in blind African clawed frog tadpoles, Xenopus laevis, a model organism used to understand development. Blackiston transplanted the eyes to unusual places, such as the back of the head or even the tail, to test the integration of transplanted sensory organs.1 The eye axons extended to either the gut or spinal cord. In a display of dynamic plasticity, transplanted eyes on the tail that extended an optic nerve into the spinal cord restored the tadpoles vision.2
Levin and Blackiston decided to explore this remarkable ability to adapt to changes in function and connectivity, a key feature for regenerative medicine applications. By leveraging natures proficiency in building and rebuilding, they wanted to understand the limits of cell and tissue plasticity outside of their natural contexts to perform new functions.
Its more like craftsmanship than it is science at times because youre doing very fine manipulations.
Douglas Blackiston, Tufts University
In a similar vein, Josh Bongard, an evolutionary roboticist at the University of Vermont and Levins longtime colleague, pondered how robots could evolve like animals. He wanted to apply biological evolution to a machine by tinkering with the brains and bodies of robots and explored this idea with Sam Kriegman, then a graduate student in Bongards group and now an assistant professor at Northwestern University. Kriegman used evolutionary algorithms and artificial intelligence (AI) to simulate biological evolution in a virtual creature before teaming up with engineers to construct a physical version.
Levins biology and Bongards computational work intersected for a program called Lifelong Learning Machines(L2M). With this project, the researchers aimed to understand how biological systems adapt to their environments and integrate these living algorithms into robotics. Together, the team dovetailed developmental biology using different biological tissues as the building blocks and AI programs to generate synthetic lifeforms as the blueprints for biological robots (biobots), also known as xenobots.
At the beginning of this project, the team planned to build lifelong learning machines from AI systems, which was a challenging enterprise. Kriegman used evolutionary algorithms to design and evolve synthetic lifeforms in simulation, but the major stumbling block lay in translating these designs to the physical world. During weekly virtual meetings between the biologists and roboticists, Bongard recalled explaining to the biologist group what was easy and hard for roboticists to do; the conventional materials used to construct robots werent working.
Josh Bongard, Michael Levin, Douglas Blackiston, and Sam Kriegman (left to right) teamed up to build synthetic organisms with an unlikely building material: frog stem cells.
Its really difficult to realize [this idea] in hardware; no ones figured out how to create a robot that crawls out of a 3D printer, explained Kriegman. We tried to build robots out of rubber, 3D printers, and electronics, but theres always this problem. Its very difficult.
As Kriegman presented a video of little blob-like robots running around in a virtual environment, he described this challenge to the team. Within the computer simulations, these robots could be manipulated like a video game; it was easy to simulate physics principles like friction or modulate the virtual environment. However, the roboticists didnt think that they could translate these theoretical designs and simulations into the real world with the existing tools.
Blackiston rose to the challenge. He conceptualized a virtual robot built out of a different material: cells. In developmental biology and stem cell biology, this isnt a super difficult trick because the technology exists, but no ones thought about doing this, said Blackiston.
Blackiston got to work in the laboratory using extra cells from his X. laevis project. Through delicate micromanipulations of stem cells in the microscope room, he crafted a replica of Kriegmans virtual creature. About a week after Kriegman shared his simulations, Blackiston revealed his creation, affectionately dubbed the Bongard-bot, in a Slack thread.
When Sam and I were looking at this image, we werent sure what we were looking at. It looked like Sams virtual robot that he had shown the week before, but it was clearly made of cells, said Bongard. Although it was a rough approximation, floating in freshwater at only a few millimeters wide, it matched the virtual design.
While this creation emerged as an unexpected tangent to the initial L2M goal, it quickly became clear that this approach could breathe life into their simulations. Levin and Bongard encouraged Blackiston and Kriegman to explore this whole new space, moving between running thousands of simulations and sculpting the best designs out of cells. From there on, it was off to the races, recalled Kriegman.
See also: https://www.the-scientist.com/how-groups-of-cells-cooperate-to-build-organs-and-organisms-67881
Since the initial biobot remained static, the team wanted to see if they could make the newer version move. Kriegman initiated the iterative design of synthetic living machines by using AI to create virtual creatures; these innocuous blobs shuffled along the floor of a virtual world before gradually developing proto-legs or -arms. Then he and Blackiston selected the most viable designs to construct out of frog cells.
Xenobots are AI-designed organisms (red) crafted from frog stem cells (green).
In his initial simulations3 for locomotion, Kriegman based the iterations on frog skin and heart cells given their propensities to aggregate and contract, respectively.3 With heart cells, they hoped to leverage motor movements from the heart muscle, like a piston, that would coordinate a form of locomotion.
Kriegman needed the computer to determine the optimal position and shape for these cellular motors in the xenobots. However, there was no guarantee that the evolved simulation would be feasible in the real world. With limited information, Kriegman sought the expertise of heart researchers to gain some insights into heart cell synchronization and to learn how unconventional shapes may influence cellular function. We know how these cells work in the heart shape, but what would happen with these cells in the context of xenobots? he wondered. Its difficult to predict ahead of time, so the AI or evolutionary algorithm must find designs that work regardless of how the motors are moving. Its making reliable machines with unreliable parts.
The team had to get creative during this process. Based on the AI, Doug would build it, and then they would modify the AI and build the next iteration, recalled Levin. Going back and forth, it was amazing because every week there was something new to look at.
Its a great reminder that when it comes to robotics and AI, humans tend to overthink things. Its better to let evolution, either biological or artificial, figure out how much complexity is needed for the task at hand.
Josh Bongard, University of Vermont
As Kriegman generated numerous iterations of xenobots, Blackiston used the 3D image as the working blueprint in his microscope room. Blackiston gathered his ingredients using different biological tissues harvested from blastula stage X. laevis embryos. Then, as if building a sandwich, he arranged the different cell layers one at a time into a cube of tissue.
When the tissue healed together, it formed a sphere. Then Blackiston sculpted the tissue using a microsurgical tool with a wire smaller than a human hair to achieve the desired shape. Each cell type differed by color, and he rotated between filters to maintain the correct orientation. Its more like craftsmanship than it is science at times because youre doing very fine manipulations, remarked Blackiston. The final product resembled a speck of pepper moving in a petri dish. These biodegradable xenobots lived for about a week, sustaining themselves on their own food source (a yolk of lipid and protein deposits) before they degraded and ceased functioning.
One of the designs featured heart muscle cells on the bottom and skin cells on top with two stumpy legs on one side. As a result, it leaned over on its chest and could walk by moving forward in a straight line. However, when flipped onto its back, the simulated design became immobile due to the alteration in shape and tissue distribution. To verify whether the computer-generated in silico matched what was created in the laboratory, Kriegman compared the trajectories of the physical xenobot and those of the virtual xenobot. To the teams surprise, the two trajectories almost perfectly overlapped with one another. It wasnt just for one trajectory; there were lots of pairs, recalled Bongard. It confirmed that what happened in simulation matched what happened in reality.
The team next wanted to see if they could make a xenobot swim. To do this, the researchers employed another type of motor: cilia.4 Instead of layering different tissues, Blackiston used whole explants from developing frog embryos.
These explants, known as animal caps, have been used to study cell differentiation and tissue formation.5 The team repurposed the animal cap to create living machines with new specific functions. Once the X. laevis explants balled up into a spherical mass, they gained motility from cilia, which propelled them through their aqueous environments.
While their movements were less predictable compared to their walking counterparts, these ciliated xenobots could navigate. The xenobots swam through open fields, mazes, and even narrow capillaries. In environments with debris or silicone-coated beads, xenobots collectively swarmed together to push the debris into piles.
Not only did the xenobots demonstrate self-locomotion, but they could also be modified to record an experience. The team tested the biobots ability to sense their environments by microinjecting mRNA with a photoconvertible reporter that caused them to fluoresce green. Xenobots freely explored their surroundings, but if any xenobot passed through an area exposed to blue light, the reporter underwent a permanent conformational change, causing the xenobot to glow red. Otherwise, xenobots glowed green to indicate that they did not detect the blue light.
Xenobots also exhibited inherent robustness and could automatically self-repair after injury from surgical forceps. Every single xenobot could close a wound, resolve the injury, and reform into a spherical shape within minutes. From a robotics perspective, cells are like a technology from a thousand years in the future that have just been plopped on our desks. They work when you stick them together. They survive; theyre self-powered; and they heal, remarked Kriegman.
See also:https://www.the-scientist.com/xenobot-living-robots-can-reproduce-69477
As they watched the xenobots scoot and shuffle across the dish and push debris into piles, the researchers envisioned adding another feature. If the debris was replaced with other materials such as stem cells or even microplastics, the ability to collect materials could open up new areas for xenobot applications. They just needed a new design.
The presence of cilia, marked in orange fluorescence, enabled xenobots to swim in their environments.
The initial spheroid shape wasnt the best for this task. When Kriegman returned to the computer drawing board, he was surprised by the simplicity of the suggested design: a C-shape. Its a great reminder that when it comes to robotics and AI, humans tend to overthink things. Its better to let evolution, either biological or artificial, figure out how much complexity is needed for the task at hand, said Bongard.
This C-shape, reminiscent of Pac-Man or a snowplow, led to an unexpected discovery. C-shaped xenobots spontaneously replicated in a manner dubbed as kinematic self-replication.6 When the team replaced debris with loose, white-colored stem cells, the xenobots immediately set to work collecting cells.
Over time, the piles of collected cells grew big enough to begin swimming themselves. These baby xenobots, although smaller than their makers, were created without evolution or genetic manipulation. Interestingly, this process occurred entirely within the dish. If there werent enough loose cells around, self-replication ceased; parent xenobots could only produce a round or two of self-replication before petering out.
The concept of kinematic self-replication was first proposed in the 1940s by a mathematician named John von Neumann.7 In this hypothetical model, a machine could assemble parts to create a duplicate of itself. However, true replication only occurs in nature, while machine replication is limited to generating computer viruses. [With xenobots], this is a new way that people havent thought about where biological systems, namely cell clusters, can replicate, said Kriegman. Maybe this will help people think differently about replication.
By leveraging existing techniques, the team built something that was not found in nature and reconfigured it to fulfill a new function. These xenobots have challenged conventional categories: Are they robots, living things, or machines? While the categorization of these synthetic living organisms may need to be redefined into a new box altogether, one thing remains certain: the team has only scratched the surface of biobots capabilities.
Its a green technology in every sense of the word. What is the probability that it will never have an application? To me, Im biased, but I think its close to zero. Its going to find a use somewhere, but who knows how many uses and how long it will take? said Bongard.
People thought this was a one-off froggy specific result, but this is a very profound thing. Whats the furthest from an embryonic frog? Well, that would be an adult human.
Michael Levin, Tufts University
Potential avenues for these biodegradable machines primarily revolve around environmental applications, from serving as biosensors to detect pollutants to gathering materials like microplastics or even sequestering and breaking down harmful chemicals.
People thought this was a one-off froggy-specific result, but this is a very profound thing, emphasized Levin. To demonstrate its translatability in a non-frog model, he wondered, Whats the furthest from an embryonic frog? Well, that would be an adult human.
He enlisted the help of Gizem Gumuskaya, a synthetic biologist with an architectural background in Levins group, to tackle this challenge of creating biological robots using human cells to create anthrobots.8 While Gumuskaya was not involved with the development of xenobots, she drew inspiration from their design. By using adult human tracheal cells, she found that adult cells still displayed morphologic plasticity.
Xenobots (C-shaped; beige) push loose stem cells (specks; white) into piles as they move through their environments.
The resulting anthrobots swam using cilia, but they unexpectedly also moved across a layer of damaged human neurons. To Gumuskayas surprise, the anthrobots aggregated and formed what she described as an ant bridge between the two damaged edges. While how they accomplished this remains unknown, the anthrobots aided in healing the neuronal tear, indicating that they may offer therapeutic potential.
There are several key differences between xenobots and anthrobots: species, cell source (embryonic or adult), and the anthrobots ability to self-assemble without manipulation. When considering applications, as a rule of thumb, xenobots are better suited to the environment. They exhibit higher durability, require less maintenance, and can coexist within the environment, said Gumuskaya.
Meanwhile, there is greater potential for the use of mammalian-derived biobots in biomedical applications. This could include localized drug delivery, deposition into the arteries to break up plaque buildup, or deploying anthrobots into tissue to act as biosensors. [Anthrobots] are poised as a personalized agent with the same DNA but new functionality, remarked Gumuskaya.
Gumuskaya hopes that this work in frogs and human cells inspires the scientific community to explore the new and unexpected functionalities of these bioconstructs. There are a lot of big challenges in this world, but were developing new kinds of technologies and tools for the next generation. I hope that these bots become one tool in that toolkit, remarked Bongard.
References
Read the original:
From Code to Creature - The Scientist